Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis.
Diamantis I TsilimigrasJ Madison HyerAnghela Z ParedesAslam EjazJordan M CloydJoal D BeaneMary DillhoffAllan TsungTimothy M PawlikPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2021)
Primary GI-NET resection was associated with a survival benefit among individuals presenting with metastatic GI-NET with unresected metastases. Resection of primary GI-NET among patients with stage IV disease and unresected metastases should only be performed in selected cases following multi-disciplinary evaluation.